Upcoming 2019 Health Plan Compliance Deadlines – September 30th for medical loss ratio (MLR) rebates, and the summary annual report. Click here for more information to determine if these deadlines pertain to your health plan.

Brown & Brown Benefit Advisors Sponsors Golf for Rob Event

June 17, 2019

Mount Laurel, NJ – Brown & Brown Benefit Advisors was a sponsor, and participant, at the Golf for Rob event on Friday, June 7th at the Ramblewood Country Club in Mount Laurel, New Jersey.  It is the annual signature event of BBBA’s Senior Account Specialist Ashley Stoffel and her family’s organization.  Their New Jersey-based 501(c)(3) charitable organization is focused on raising funds for Melanoma Cancer Research.  Golf for Rob was incorporated in 2016 in honor of Robert Stoffel, Ashley’s father.  Although he was highly accomplished, his life was cut short by Melanoma.  The organization’s mission is to drive out cancer with their main fundraising activity being the annual golf outing.

Pictured, left to right:  Joan Stoffel, Jessica Stoffel, Greg Mumford, Ashley Stoffel, Michael Stoffel, Alexis Stoffel, Orsula Stoffel

Each year the organization donates proceeds from the event to fund Melanoma research.  In 2017 a $25,000 donation was made to researchers at the University of Pennsylvania and Yale School of Medicine. The Robert Stoffel Memorial Foundation was established in 2018 at the University of Pennsylvania’s Abramson Cancer Center and all proceeds are now donated to this foundation.  In that year, over $35,000 was raised for the foundation, and at this year’s event over $33,000 was raised and donated.

The University of Pennsylvania explains the research that Golf for Rob specifically donates towards:

Thanks to support from Golf for Rob, Dr. Alexander Huang of Penn Medicine’s Abramson Cancer Center was able to advance critical research with a goal of learning which patients benefit from melanoma immunotherapy. Dr. Huang, in conjunction with Penn colleagues Dr. Tara Mitchell and Dr. John Wherry, previously learned that an immune response in the blood could be predicted three weeks after receiving anti-PD-1 therapy. The team then designed and implemented a clinical trial giving patients anti-PD-1 therapy before surgery. The study found that 30% of patients had complete or near-complete shrinkage of their tumor after a single dose, and all of these patients remain disease-free. Tumor shrinkage was identified by imaging at three weeks—leading to the prediction that immune response happens even earlier than previously anticipated. After testing this theory within a second cohort, the team found that the immune response peaks as early as one week after therapy—a finding that has resulted in a paper now published in Nature Medicine.

The full-day event attracted 115 golfers with prizes given out to the 1st place foursome, Longest Drive, Closest to the Pin and a Putting Contest; dinner and a silent auction wrapped up the day with even more people in attendance.  The event organizers have already started planning for 2020.  For more information about the organization and their mission, visit www.golfforrob.com.


Brown & Brown Benefit Advisors